These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1575203)

  • 21. Effect of granulocyte colony-stimulating factor on granulopoiesis of congenital neutropenic children.
    Benkö I; Maródi L; Megyeri A; Káposzta R; Kovács P
    Acta Physiol Hung; 1996; 84(3):261-2. PubMed ID: 9219597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of neonatal myelopoiesis in newborn rats after 7 days' administration of either granulocyte-monocyte colony stimulating factor or interleukin-3.
    Cairo MS; Mauss D; Plunkett JM; Gillis S; van de Ven C
    Pediatr Res; 1991 May; 29(5):504-9. PubMed ID: 1896256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease.
    Taylor KM; Jagannath S; Spitzer G; Spinolo JA; Tucker SL; Fogel B; Cabanillas FF; Hagemeister FB; Souza LM
    J Clin Oncol; 1989 Dec; 7(12):1791-9. PubMed ID: 2479719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human granulocyte-macrophage colony-stimulating factor promotes megakaryocyte maturation in nonhuman primates.
    Stahl CP; Winton EF; Monroe MC; Holman RC; Zelasky M; Liehl E; Myers LA; McClure H; Anderson D; Evatt BL
    Exp Hematol; 1991 Sep; 19(8):810-6. PubMed ID: 1868895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation.
    Peters WP; Kurtzberg J; Atwater S; Borowitz M; Rao M; Currie M; Gilbert C; Shpall EJ; Jones RB; Ross M
    Prog Clin Biol Res; 1990; 338():121-8. PubMed ID: 2189135
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of rhIL-11 on normal dogs and after sublethal radiation.
    Nash RA; Seidel K; Storb R; Slichter S; Schuening FG; Appelbaum FR; Becker AB; Bolles L; Deeg HJ; Graham T
    Exp Hematol; 1995 May; 23(5):389-96. PubMed ID: 7720811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term in vivo priming of bone marrow haematopoiesis with rhG-CSF, rhGM-CSF or rhIL-3 before marrow harvest expands myelopoiesis but does not improve engraftment capability.
    Hansen PB; Knudsen H; Gaarsdal E; Jensen L; Ralfkiaer E; Johnsen HE
    Bone Marrow Transplant; 1995 Sep; 16(3):373-9. PubMed ID: 8535309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trial.
    Vose JM; Pandite AN; Beveridge RA; Geller RB; Schuster MW; Anderson JE; LeMaistre CF; Ahmed T; Granena A; Keating A; Fernandez Ranada JM; Stiff PJ; Tabbara I; Longo W; Copelan EA; Nichols C; Smith A; Topolsky DL; Bierman PJ; Lebsack ME; Lange M; Garrison L
    J Clin Oncol; 1997 Apr; 15(4):1617-23. PubMed ID: 9193361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of combined treatment with interleukin 1 and erythropoietin or GM-CSF and erythropoietin on the regeneration of hemopoiesis in the dog after total body irradiation--a preliminary report.
    Selig C; Nothdurft W; Kreja L; Fliedner TM
    Behring Inst Mitt; 1991 Dec; (90):86-92. PubMed ID: 1801695
    [No Abstract]   [Full Text] [Related]  

  • 31. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
    Winter JN; Lazarus HM; Rademaker A; Villa M; Mangan C; Tallman M; Jahnke L; Gordon L; Newman S; Byrd K; Cooper BW; Horvath N; Crum E; Stadtmauer EA; Conklin E; Bauman A; Martin J; Goolsby C; Gerson SL; Bender J; O'Gorman M
    J Clin Oncol; 1996 Jan; 14(1):277-86. PubMed ID: 8558209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokines in anticancer therapy.
    Khan IU; Shear NH
    Clin Dermatol; 1991; 9(4):523-33. PubMed ID: 1726586
    [No Abstract]   [Full Text] [Related]  

  • 33. Granulocyte-macrophage colony-stimulating factor with induction treatment of acute myelogenous leukemia.
    Adkins DR; Brown RA; DiPersio JF
    J Clin Oncol; 1997 Feb; 15(2):862-3. PubMed ID: 9053516
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhanced myelopoiesis in long-term cultures of human bone marrow pretreated with recombinant granulocyte-macrophage colony-stimulating factor.
    Haas R; Ogniben E; Kiesel S; Hohaus S; Baumann M; Körbling M; Dörken B; Hunstein W
    Exp Hematol; 1989 Mar; 17(3):235-9. PubMed ID: 2645156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
    Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A
    Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor.
    Vadhan-Raj S; Buescher S; Broxmeyer HE; LeMaistre A; Lepe-Zuniga JL; Ventura G; Jeha S; Horwitz LJ; Trujillo JM; Gillis S
    N Engl J Med; 1988 Dec; 319(25):1628-34. PubMed ID: 3059191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. G-CSF is a major component of colony-stimulating activity (CSA) in the plasma of patients with multiple myeloma after treatment with high-dose melphalan (HDM).
    Joffe JK; Bell JB; Denham S; Adshead F; Millar JL; Millar BC
    Exp Hematol; 1995 Apr; 23(4):376-82. PubMed ID: 7534716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor.
    Armitage JO
    Blood; 1998 Dec; 92(12):4491-508. PubMed ID: 9845514
    [No Abstract]   [Full Text] [Related]  

  • 39. Emerging clinical uses for GM-CSF.
    Scarffe JH
    Eur J Cancer; 1991; 27(11):1493-504. PubMed ID: 1835868
    [No Abstract]   [Full Text] [Related]  

  • 40. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
    Lieschke GJ; Maher D; O'Connor M; Green M; Sheridan W; Rallings M; Bonnem E; Burgess AW; McGrath K; Fox RM
    Cancer Res; 1990 Feb; 50(3):606-14. PubMed ID: 2404573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.